CLINICAL_TRIALS
trial_result
· 2023-11-07
Clinical Trial Update: Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) [Phase 1, Phase 2]
Summary
A completed Phase 1/2 clinical trial evaluating stem cell transplantation for Juvenile Myelomonocytic Leukemia (JMML) conducted by Masonic Cancer Center, Univer…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Juvenile Myelomonocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-11-07